Company Analysis Novo Nordisk A/S
1. Summary
Advantages
- Price (81.05 $) is less than fair price (175.39 $)
- Dividends (1.74%) are higher than the sector average (1.28%).
- The company's current efficiency (ROE=80.78%) is higher than the sector average (ROE=-83.36%)
Disadvantages
- The stock's return over the last year (-41.95%) is lower than the sector average (-29.3%).
- Current debt level 22.07% has increased over 5 years from 3.57%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Novo Nordisk A/S | Healthcare | Index | |
|---|---|---|---|
| 7 days | 5.8% | 3.5% | -0.1% |
| 90 days | 30.4% | -28.5% | 6.8% |
| 1 year | -42% | -29.3% | 10.9% |
NVO vs Sector: Novo Nordisk A/S has significantly underperformed the "Healthcare" sector by -12.65% over the past year.
NVO vs Market: Novo Nordisk A/S has significantly underperformed the market by -52.84% over the past year.
Stable price: NVO is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: NVO with weekly volatility of -0.8067% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (81.05 $) is lower than the fair price (175.39 $).
Price significantly below the fair price: The current price (81.05 $) is 116.4% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (27.15) is lower than that of the sector as a whole (53.16).
P/E vs Market: The company's P/E (27.15) is lower than that of the market as a whole (62.08).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (19.11) is higher than that of the sector as a whole (10.88).
P/BV vs Market: The company's P/BV (19.11) is lower than that of the market as a whole (20.84).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (9.44) is higher than that of the sector as a whole (4.06).
P/S vs Market: The company's P/S indicator (9.44) is lower than that of the market as a whole (16.02).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (20.59) is higher than that of the sector as a whole (16.9).
EV/Ebitda vs Market: The company's EV/Ebitda (20.59) is lower than that of the market as a whole (27.1).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 27.93% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (27.93%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.32%).
5.4. ROE
ROE vs Sector: The company's ROE (80.78%) is higher than that of the sector as a whole (-83.36%).
ROE vs Market: The company's ROE (80.78%) is higher than that of the market as a whole (43%).
5.5. ROA
ROA vs Sector: The company's ROA (25.89%) is higher than that of the sector as a whole (6.41%).
ROA vs Market: The company's ROA (25.89%) is higher than that of the market as a whole (23.28%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (63.87%) is higher than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (63.87%) is higher than that of the market as a whole (9.2%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 1.74% is higher than the average for the sector '1.28%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.74% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 1.74% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (43.71%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
